May 26, 2011
By:
Erik Greb
Global spending on medicines will total almost $1.1 trillion by 2015, according to an IMS Institute for Healthcare Informatics study.
|
May 19, 2011
By:
Erik Greb
Teva Pharmaceutical Industries agreed to pay shareholders $460 million in cash to acquire a 57% stake in Taiyo Pharmaceutical Industry. Teva also will offer to buy all outstanding shares of Taiyo.
|
May 18, 2011
By:
Erik Greb
Recent recalls, including that of American Regent?s caffeine and sodium benzoate injection on May 5, 2011, highlight the importance of particulate inspection, and they might lead observers to ask whether current inspection methods are sufficiently effective.
|
May 12, 2011
By:
Erik Greb
In fiscal year 2010, the number of patent settlements in which the manufacturers of branded products paid makers of generic drugs to postpone the introduction of their products reached its highest level ever, according to the Federal Trade Commission.
|
May 5, 2011
By:
Erik Greb
The IPEC is soliciting public comment about a draft plan for the independent certification of manufacturers and suppliers of pharmaceutical excipients.
|
|
Emerging methods could provide alternative ways of producing inhalable drug particles.
May 2, 2011
By:
Erik Greb
Emerging methods could provide alternative ways of producing inhalable drug particles.
|
Can the semiconductor industry help Big Pharma develop therapies?
May 2, 2011
By:
Erik Greb
Can the semiconductor industry help Big Pharma develop therapies?
|
Apr 21, 2011
By:
Erik Greb
On Tuesday, Apr. 19, 2011, officials from FDA, the US Department of Health and Human Services, and the Drug Enforcement Administration introduced President Obama?s plan for curbing prescription-drug diversion and abuse.
|
Apr 20, 2011
By:
Erik Greb
To find out how well industry is applying QbD, and what benefits the approach can bring, Equipment and Processing Report talked to Moheb M. Nasr, director of FDA?s Office of New Drug Quality Assessment.
|
|
